Clene Inc (CLNN)
0.3772
-0.01
(-2.18%)
USD |
NASDAQ |
May 17, 16:00
0.3772
0.00 (0.00%)
After-Hours: 20:00
Clene 1 Year Total Returns (Daily): -59.78% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -59.78% |
May 16, 2024 | -57.16% |
May 15, 2024 | -57.25% |
May 14, 2024 | -56.35% |
May 13, 2024 | -55.59% |
May 10, 2024 | -57.15% |
May 09, 2024 | -58.39% |
May 08, 2024 | -58.30% |
May 07, 2024 | -58.36% |
May 06, 2024 | -54.94% |
May 03, 2024 | -53.29% |
May 02, 2024 | -53.64% |
May 01, 2024 | -54.72% |
April 30, 2024 | -54.55% |
April 29, 2024 | -62.98% |
April 26, 2024 | -64.24% |
April 25, 2024 | -63.52% |
April 24, 2024 | -65.61% |
April 23, 2024 | -65.44% |
April 22, 2024 | -65.66% |
April 19, 2024 | -64.95% |
April 18, 2024 | -66.62% |
April 17, 2024 | -67.03% |
April 16, 2024 | -70.48% |
April 15, 2024 | -68.44% |
Date | Value |
---|---|
April 12, 2024 | -67.30% |
April 11, 2024 | -64.74% |
April 10, 2024 | -63.85% |
April 09, 2024 | -65.31% |
April 08, 2024 | -64.69% |
April 05, 2024 | -64.03% |
April 04, 2024 | -65.37% |
April 03, 2024 | -63.66% |
April 02, 2024 | -64.96% |
April 01, 2024 | -62.84% |
March 28, 2024 | -61.33% |
March 27, 2024 | -63.04% |
March 26, 2024 | -63.12% |
March 25, 2024 | -62.61% |
March 22, 2024 | -61.72% |
March 21, 2024 | -65.31% |
March 20, 2024 | -66.10% |
March 19, 2024 | -68.42% |
March 18, 2024 | -67.97% |
March 15, 2024 | -69.47% |
March 14, 2024 | -67.94% |
March 13, 2024 | -67.68% |
March 12, 2024 | -64.76% |
March 11, 2024 | -64.68% |
March 08, 2024 | -61.54% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.54%
Minimum
Nov 10 2022
54.80%
Maximum
Feb 16 2021
-35.92%
Average
-50.94%
Median
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -52.96% |
AIM ImmunoTech Inc | -19.40% |
IGC Pharma Inc | 69.70% |
NovaBay Pharmaceuticals Inc | -83.53% |
Protalix BioTherapeutics Inc | -51.69% |